Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T K Chan

Showing results (31-40 of 267) with videos related to

Pageof 27
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1988
HOAP-Bleo as salvage therapy for diffuse aggressive non-Hodgkin's lymphomaR Liang, D Todd, T K Chan
Cancer Chemotherapy and Pharmacology|January 1, 1988
Chemotherapy for relapsed and resistant acute nonlymphoblastic leukemia. Effect of ATA, an amsacrine-containing regimeR Liang, T K Chan, D Todd
International Endodontic Journal|March 27, 2003
Long-term survival of primary root canal treatment carried out in a dental teaching hospitalG S P Cheung, T K Chan
Journal of Andrology|June 18, 2002
Inflammatory conditions of the male excurrent ductal system. Part IPeter T K Chan, Peter N Schlegel
British Journal of Haematology|December 1, 1994
Intragenic dinucleotide repeats in factor VIII gene for the diagnosis of haemophilia AB Yip, V Chan, T K Chan
Leukemia & Lymphoma|May 1, 1994
Childhood acute lymphoblastic leukaemia and aplastic anaemiaR Liang, T K Chan, D Todd
Chinese Medical Journal|June 1, 1997
Alpha and beta thalassemias in Hong KongV Chan, T K Chan, D Todd
Journal of Andrology|June 18, 2002
Inflammatory conditions of the male excurrent ductal system. Part IIPeter T K Chan, Peter N Schlegel
Emergency Medicine Journal : EMJ|September 5, 2003
A pragmatic approach to timely disease surveillance in the emergency departmentJ T K Chan, P A Cameron
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|December 7, 2013
Low-dose subcutaneous alemtuzumab is a safe and effective treatment for chronic acquired pure red cell aplasiaJason K W Chow, T K Chan
Pageof 27

Showing results (31-40 of 267) with videos related to

Sort By:
Pageof 27
Cancer Chemotherapy and Pharmacology|January 1, 1988
HOAP-Bleo as salvage therapy for diffuse aggressive non-Hodgkin's lymphomaR Liang, D Todd, T K Chan
Cancer Chemotherapy and Pharmacology|January 1, 1988
Chemotherapy for relapsed and resistant acute nonlymphoblastic leukemia. Effect of ATA, an amsacrine-containing regimeR Liang, T K Chan, D Todd
International Endodontic Journal|March 27, 2003
Long-term survival of primary root canal treatment carried out in a dental teaching hospitalG S P Cheung, T K Chan
Journal of Andrology|June 18, 2002
Inflammatory conditions of the male excurrent ductal system. Part IPeter T K Chan, Peter N Schlegel
British Journal of Haematology|December 1, 1994
Intragenic dinucleotide repeats in factor VIII gene for the diagnosis of haemophilia AB Yip, V Chan, T K Chan
Leukemia & Lymphoma|May 1, 1994
Childhood acute lymphoblastic leukaemia and aplastic anaemiaR Liang, T K Chan, D Todd
Chinese Medical Journal|June 1, 1997
Alpha and beta thalassemias in Hong KongV Chan, T K Chan, D Todd
Journal of Andrology|June 18, 2002
Inflammatory conditions of the male excurrent ductal system. Part IIPeter T K Chan, Peter N Schlegel
Emergency Medicine Journal : EMJ|September 5, 2003
A pragmatic approach to timely disease surveillance in the emergency departmentJ T K Chan, P A Cameron
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|December 7, 2013
Low-dose subcutaneous alemtuzumab is a safe and effective treatment for chronic acquired pure red cell aplasiaJason K W Chow, T K Chan
Pageof 27